PKR
Author:
Sadler Anthony John
Publisher
Springer New York
Reference68 articles.
1. Abraham N, Stojdl DF, Duncan PI, Methot N, Ishii T, Dube M, et al. Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase PKR. J Biol Chem. 1999;274(9):5953–62. 2. Barber GN, Edelhoff S, Katze MG, Disteche CM. Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PRKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2. Genomics. 1993;16(3):765–7. 3. Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell. 2002;108(2):221–32. 4. Blalock WL, Piazzi M, Bavelloni A, Raffini M, Faenza I, D’Angelo A, et al. Identification of the PKR nuclear interactome reveals roles in ribosome biogenesis, mRNA processing and cell division. J Cell Physiol. 2014;229(8):1047–60. 5. Bommer UA, Borovjagin AV, Greagg MA, Jeffrey IW, Russell P, Laing KG, et al. The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR. RNA. 2002;8(4):478–96.
|
|